Hartford Great Health Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HFUS research report →
Price Chart
About the company
Hartford Great Health Corp. operates within the hospitality industry, distinguishing its operations across two primary segments: Hospitality and Education. Its hospitality division delivers both hotel and travel agency services.
- CEO
- Sheng-Yih Chang
- IPO
- 2012
- Employees
- 19
- HQ
- Rosemead, CA, US
Get TickerSpark's AI analysis on HFUS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $100.11M
- P/E
- 74.07
- PEG
- 0.27
- P/S
- 41.53
- P/B
- 107.10
- EV/EBITDA
- 61.84
- Div Yield
- 0.00%
- Gross Margin
- 99.84%
- Op Margin
- 68.19%
- Net Margin
- 56.07%
- ROE
- 278.52%
- ROIC
- 51.12%
Latest fiscal year · YoY change
- Revenue
- $2.04M+45.4%
- Gross Profit
- $1.93M+43.2%
- Op Income
- $1.23M
- Net Income
- $1.10M+0.6%
- EPS
- $0.04+302.8%
- OCF Growth
- -101.5%
- FCF Growth
- -101.6%
- 52W High
- $7.52
- 52W Low
- $1.99
- 50D MA
- $4.00
- 200D MA
- $4.23
- Beta
- 0.55
- RSI (14)
- 47
- Avg Volume
- 3
No earnings-call transcripts are available for HFUS yet.
- Free Float
- 10.7%
- Shares Outstanding
- 25.03M
- Float Shares
- 2.69M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 26, 24 | Song Lianyue | sell | 35,484,880 |
| Nov 26, 24 | Chang Sheng-Yih | buy | 43,786,800 |
| Nov 26, 24 | Songwang Erin | other | 0 |
| Nov 26, 24 | Songwang Erin | other | 0 |
| Oct 31, 24 | Song Lianyue | sell | 32,700,000 |
| Oct 31, 24 | Chang Sheng-Yih | buy | 400,000 |
| Oct 31, 24 | Lu Yuan | sell | 4,800,000 |
| Oct 31, 24 | Dong Xin | sell | 4,800,000 |
| Apr 1, 24 | Dai Lili | other | 0 |
| Mar 19, 24 | Wang Rose Hong | buy | 2,940,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HFUS coverage
Recent articles, reports, and earnings notes.
No research on HFUS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HFUS report →